SCHEMBL29944868

SCHEMBL29944868

CCOC(=O)c1cccc(NC(=O)c2sccc2S(=O)(=O)N(C)c2ccc(OC(C)C)cc2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 13/20 0.80
NR1H3 Q13133 10/20 0.80
NR1H2 P55055 10/20 0.80
RAB9A P51151 4/20 0.52
NPC1 O15118 3/20 0.52
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPK1 P28482 2/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
HSD17B10 Q99714 2/20 0.50
TSHR P16473 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245333 1.00 SREBF1 (0.80) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27030601 0.91 SREBF1 (0.89) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27030539 0.89 SREBF1 (1.00) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27245334 0.89 SREBF1 (0.79) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL29944871 0.89 SREBF1 (0.79) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27030583 0.89 SREBF1 (0.63) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27245361 0.88 SREBF1 (0.89) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL29944859 0.88 SREBF1 (0.89) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27030659 0.87 SREBF1 (0.76) SREBF1NR1H3NR1H2RAB9ANPC1
SCHEMBL27245362 0.87 SREBF1 (0.79) SREBF1NR1H3NR1H2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed